News
News
PublISHED ON
UpDATED ON
10 million SEK to national study of COVID-19
The Swedish Research Council is providing 10 million SEK to fund the ImmCoVA clinical study. The study is expected to run for three years, and focuses on immune blockers to counteract excess reaction of the immune system to the infection caused by COVID-19.
Foto: Chris McLay, Unsplash
In June, we reported that the Swedish Research Council was to fund Sweden’s participation in the Solidarity trial, a major clinical WHO study, where a number of antiviral medicines are tested on patients being treated for COVID-19. However, due to the high level of mortality seen in patients receiving some of these medicines, the Swedish network for the WHO study decided that Sweden would not participate in the study.
Instead, the Swedish Research Council is now providing the same network of infection clinics in Sweden with funding of 10 million SEK to conduct another national study into COVID-19. The study is called ImmCoVA, and is expected to run for three years, starting in October. The study focuses on immune blockers to counteract excess reaction of the immune system to infection, known as ‘cytokine storm’. The study will investigate whether treatment with two specific immunosuppressing substances can result in improvement, and at best in patients recovering more quickly than with standard treatments.
The Karolinska University Hospital is leading the study, and patients will be recruited from five university hospitals.
MORE WITHIN THE SAME SUBJECT AREA
-
News |
Published 13 February 2025
In April, we will open four calls for proposals, in addition to those previously announced for 2025.
-
News |
Published 30 December 2024
This year, the Swedish Research Council received around 5 800 applications for research grants. 860 of these were awarded funding. In total, 4.55 billion SEK has been awarded to research at Swedish higher education institutions, and 2.81 billion SEK ...
-
News |
Published 17 December 2024
The elector council has now appointed new members of the Swedish Research Council’s board and scientific councils for the period 2025–2027. The mandate period is three years, and members may be reappointed for a further three-year period.